| Target Price | $296.82 |
| Price | $269.89 |
| Potential | 9.98% |
| Number of Estimates | 22 |
| 22 Analysts have issued a price target Travelers 2026 . The average Travelers target price is $296.82. This is 9.98% higher than the current stock price. The highest price target is $336.00 24.50% , the lowest is $228.82 15.22% . | |
| A rating was issued by 30 analysts: 12 Analysts recommend Travelers to buy, 16 to hold and 2 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Travelers stock has an average upside potential 2026 of 9.98% . Most analysts recommend the Travelers stock at Hold. |
18 Analysts have issued a sales forecast Travelers 2025 . The average Travelers sales estimate is $45.6b . This is 5.79% lower than the revenue of the last 12 months(TTM). The highest sales forecast is $47.8b 1.15% , the lowest is $43.9b 9.21% .
This results in the following potential growth metrics:
| 2024 | $46.4b | 12.23% |
|---|---|---|
| 2025 | $45.6b | 1.77% |
| 2026 | $47.5b | 4.20% |
| 2027 | $49.5b | 4.10% |
| 2028 | $50.7b | 2.47% |
| 2029 | $52.3b | 3.09% |
2 Analysts have issued an Travelers EBITDA forecast 2025. The average Travelers EBITDA estimate is $7.4b . This is 52.72% lower than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $7.7b 50.85% , the lowest is $7.2b 54.13% .
This results in the following potential growth metrics and future EBITDA Margins:
| 2024 | $14.3b | 33.28% |
|---|---|---|
| 2025 | $7.4b | 48.27% |
| 2026 | $8.7b | 18.30% |
| 2027 | $7.9b | 9.56% |
| 2024 | 30.74% | 18.75% |
|---|---|---|
| 2025 | 16.19% | 47.33% |
| 2026 | 18.38% | 13.53% |
| 2027 | 15.97% | 13.11% |
27 Travelers Analysts have issued a net profit forecast 2025. The average Travelers net profit estimate is $5.0b . This is 14.41% lower than the net profit for the last 12 months(TTM). The highest net profit forecast is $5.5b 5.62% , the lowest is $4.3b 26.65% .
This results in the following potential growth metrics and future Net Margins:
| 2024 | $5.0b | 67.09% |
|---|---|---|
| 2025 | $5.0b | 0.61% |
| 2026 | $5.8b | 15.53% |
| 2027 | $6.1b | 6.07% |
| 2028 | $4.8b | 22.22% |
| 2029 | $5.5b | 15.29% |
| 2024 | 10.69% | 48.88% |
|---|---|---|
| 2025 | 10.95% | 2.47% |
| 2026 | 12.14% | 10.87% |
| 2027 | 12.36% | 1.81% |
| 2028 | 9.38% | 24.11% |
| 2029 | 10.50% | 11.94% |
27 Analysts have issued a Travelers forecast for earnings per share. The average Travelers EPS is $22.38 . This is 12.68% lower than earnings per share in the financial year 2024. The highest EPS forecast is $24.68 3.71% , the lowest is $19.18 25.17% .
This results in the following potential growth metrics and future valuations:
| 2024 | $21.47 | 67.87% |
|---|---|---|
| 2025 | $22.38 | 4.24% |
| 2026 | $25.86 | 15.55% |
| 2027 | $27.43 | 6.07% |
| 2028 | $21.33 | 22.24% |
| 2029 | $24.59 | 15.28% |
| Current | 10.50 | 22.71% |
|---|---|---|
| 2025 | 12.02 | 14.48% |
| 2026 | 10.41 | 13.39% |
| 2027 | 9.81 | 5.76% |
| 2028 | 12.62 | 28.64% |
| 2029 | 10.94 | 13.31% |
Based on analysts' sales estimates for 2025, the Travelers stock is valued at an EV/Sales of 1.52 and an P/S ratio of 1.32 .
This results in the following potential growth metrics and future valuations:
| Current | 1.43 | 5.30% |
|---|---|---|
| 2025 | 1.52 | 6.27% |
| 2026 | 1.46 | 4.03% |
| 2027 | 1.40 | 3.94% |
| 2028 | 1.37 | 2.41% |
| 2029 | 1.33 | 3.00% |
| Current | 1.24 | 6.68% |
|---|---|---|
| 2025 | 1.32 | 6.15% |
| 2026 | 1.26 | 4.03% |
| 2027 | 1.21 | 3.94% |
| 2028 | 1.18 | 2.41% |
| 2029 | 1.15 | 3.00% |
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Keefe, Bruyette & Woods |
Outperform
➜
Outperform
|
Unchanged | Oct 20 2025 |
| Wells Fargo |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Oct 17 2025 |
| Piper Sandler |
Overweight
➜
Overweight
|
Unchanged | Oct 17 2025 |
| JP Morgan |
Underweight
➜
Underweight
|
Unchanged | Oct 09 2025 |
| UBS |
Neutral
➜
Neutral
|
Unchanged | Oct 08 2025 |
| Wells Fargo |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Oct 08 2025 |
| Morgan Stanley |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Oct 07 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Keefe, Bruyette & Woods:
Outperform
➜
Outperform
|
Oct 20 2025 |
|
Unchanged
Wells Fargo:
Equal-Weight
➜
Equal-Weight
|
Oct 17 2025 |
|
Unchanged
Piper Sandler:
Overweight
➜
Overweight
|
Oct 17 2025 |
|
Unchanged
JP Morgan:
Underweight
➜
Underweight
|
Oct 09 2025 |
|
Unchanged
UBS:
Neutral
➜
Neutral
|
Oct 08 2025 |
|
Unchanged
Wells Fargo:
Equal-Weight
➜
Equal-Weight
|
Oct 08 2025 |
|
Unchanged
Morgan Stanley:
Equal-Weight
➜
Equal-Weight
|
Oct 07 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


